Project Orbis For Cell Gene Therapies Gathers Momentum
Project Orbis has worked very well for oncology products. CBER Director Dr. Peter Marks has recently started promoting the development of a similar...
Source: clinicalleader.com
Page 19 - Solid Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Solid Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Solid Biosciences Today - Breaking & Trending Today
Financial Contrast: DBV Technologies (NASDAQ:DBVT) and Solid Biosciences (NASDAQ:SLDB)
DBV Technologies (NASDAQ:DBVT – Get Rating) and Solid Biosciences (NASDAQ:SLDB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability. Risk and Volatility DBV Technologies has a beta of […]
Source: modernreaders.com
Short Interest in Solid Biosciences Inc. (NASDAQ:SLDB) Increases By 71.9%
Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 36,100 shares, a growth of 71.9% from the March 15th total of 21,000 shares. Currently, 0.2% of the company’s stock are sold short. Based […]
Source: kopsource.com
MaxCyte installs Douglas Swirsky as its new finance chief
Cell engineering technology company MaxCyte announced the appointment of Douglas Swirsky as its new chief financial officer on Tuesday.
Source: sharecast.com
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
ROCKVILLE, Md., March 27, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | March 27, 2023
Source: marketscreener.com